Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1AGC Pharma Chemicals Europe, S.L.U.
03 1Glenmark Life Sciences Limited
04 1Mylan Laboratories Limited
05 1Professional Compounding Centers of America dba PCCA
06 1QIDONG DONGYUE PHARMACEUTICAL CO., LTD.
07 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
08 1Tianish Laboratories Private Limited
01 4DIPYRIDAMOLE
02 4Dipyridamole
01 1China
02 3India
03 1Italy
04 1U.S.A
05 2United Kingdom
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-122
Start Marketing Date : 2020-01-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65404-005
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66039-917
Start Marketing Date : 2015-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1571
Start Marketing Date : 2013-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 68166-003
Start Marketing Date : 2019-10-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12660-0084
Start Marketing Date : 1979-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0029
Start Marketing Date : 2024-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-782
Start Marketing Date : 2015-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Aggrenox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aggrenox, including repackagers and relabelers. The FDA regulates Aggrenox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aggrenox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aggrenox manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aggrenox supplier is an individual or a company that provides Aggrenox active pharmaceutical ingredient (API) or Aggrenox finished formulations upon request. The Aggrenox suppliers may include Aggrenox API manufacturers, exporters, distributors and traders.
click here to find a list of Aggrenox suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aggrenox as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aggrenox API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aggrenox as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aggrenox and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aggrenox NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aggrenox suppliers with NDC on PharmaCompass.
We have 8 companies offering Aggrenox
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?